US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adicet Bio, Inc.

0.5817

+0.01332.34%

Post-market: 0.60000.0183+3.15%16:19 EDT

Volume:215.53K

Turnover:124.22K

Market Cap:48.10M

PE:-0.44

High:0.5954

Open:0.5712

Low:0.5535

Close:0.5684

Loading ...

Overview Company News Filings

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

BRIEF-Adicet Bio Provides Corporate Update

Adicet Bio Inc - Patient Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25

THOMSON REUTERS

Adicet Bio Inc - Preliminary Data for Adi-001 in Ln Expected in 1H25

THOMSON REUTERS

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

THOMSON REUTERS

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCC

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of Adi-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

THOMSON REUTERS

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

BRIEF-Adicet Bio Appoints Julie Maltzman, M.D. As Chief Medical Officer

Adicet Bio Appoints Julie Maltzman, M.d. as Chief Medical Officer

THOMSON REUTERS

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC

Adicet Opens Enrollment for Adi-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACET/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","market":"US","secType":"STK","nameCN":"Adicet Bio, Inc.","latestPrice":0.5817,"timestamp":1745352000000,"preClose":0.5684,"halted":0,"volume":215532,"hourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.5817,"latestTime":"16:19 EDT","volume":696,"amount":406.6845276,"timestamp":1745353192598},"delay":0,"floatShares":61366114,"shares":82685750,"eps":-1.332954,"marketStatus":"Post-Mkt","change":0.0133,"latestTime":"04-22 16:51:40 EDT","open":0.5712,"high":0.5954,"low":0.5535,"amount":124215.929551,"amplitude":0.073716,"askPrice":0.6513,"askSize":100,"bidPrice":0.55,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.332954,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1516942800000,"exchange":"NASDAQ","adjPreClose":0.5684,"preHourTrading":{"tag":"盘前","latestPrice":0.5899,"preClose":0.5684,"latestTime":"09:04 EDT","volume":25,"amount":14.747499999999999,"timestamp":1745327047537},"postHourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.5817,"latestTime":"16:19 EDT","volume":696,"amount":406.6845276,"timestamp":1745353192598},"volumeRatio":0.611818,"impliedVol":2.2741,"impliedVolPercentile":0.952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","floatShares":61366114,"roa":"-37.31%","roe":"-65.65%","lyrEps":-1.332954,"volumeRatio":0.611818,"shares":82685750,"dividePrice":0.04,"high":0.5954,"amplitude":0.073716,"preClose":0.5684,"low":0.5535,"week52Low":0.4471,"pbRate":"0.26","week52High":2.25,"institutionHeld":0.7488,"latestPrice":0.5817,"committee":0.5,"eps":-1.332954,"divideRate":0.068764,"volume":215532,"delay":0,"ttmEps":-1.332954,"open":0.5712,"prevYearClose":0.962,"prevWeekClose":0.5258,"prevMonthClose":0.755,"prevQuarterClose":0.755,"fiveDayClose":0.566,"twentyDayClose":0.9143,"sixtyDayClose":0.9218},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACET\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508891504","title":"Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508891504","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508891504?lang=en_us&edition=fundamental","pubTime":"2025-02-01 07:06","pubTimestamp":1738364760,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, January 31, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on January 31, 2025.All of the above-described awards were granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The awards were authorized by a majority of Adicet’s independent directors or the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employees entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cance","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grants-230600745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LU2210150020.SGD","NDAQ","IE00BGHQF748.EUR","LU2210149790.SGD","BK4139","ACET","IE00B64PRP62.GBP",".IXIC","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4112","BK4588"],"gpt_icon":0},{"id":"2507687414","title":"Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507687414","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507687414?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:00","pubTimestamp":1738152000,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, January 29, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference being held from February 5-6, 2025 in New York.Details of the event are as follows:Date: Wednesday, February 5, 2025Time: 2:00 p.m. ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-participate-fireside-chat-120000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACET","BK4139","SMID","BK4011"],"gpt_icon":0},{"id":"2502083138","title":"BRIEF-Adicet Bio Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083138?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:16","pubTimestamp":1736371016,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Provides Corporate Update Jan 8 (Reuters) - Adicet Bio Inc ACET.O:ADICET BIO PROVIDES CORPORATE UPDATE AND HIGHLIGHTS EXPECTED 2025 MILESTONESADICET BIO INC - PRELIMINARY DATA FOR ADI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502083595","title":"Adicet Bio Inc - Patient Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083595?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2502083591","title":"Adicet Bio Inc - Preliminary Data for Adi-001 in Ln Expected in 1H25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083591?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502083531","title":"Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083531?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502085244","title":"Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2502085244","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502085244?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":"Adicet made significant progress in 2024 and is well-positioned for success in 2025: Advancing Phase 1 clinical trial evaluating ADI-001 across six autoimmune diseases; preliminary data in lupus nephritis  patients anticipated in 1H25, data from other patient cohorts expected in 2H25. Patient enrollment in systemic lupus erythematosus , systemic sclerosis , idiopathic inflammatory myopathy  and stiff person syndrome  expected to be initiated in 1Q25; initiation of patient enrollment in anti-neutrophil cytoplasmic autoantibody  associated vasculitis  expected in 2H25. REDWOOD CITY, Calif. & BOSTON, January 08, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and highlighted upcoming milestones for 2025.In September 2024, Adicet presented clinical biomarker data from the Phase 1 GLEAN trial of ADI-001 at the 9th Annual CAR-TCR Summit dem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-provides-corporate-highlights-211000326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4077","BK4230","CAR","BK4022","ACET","SLE","IIM","BK4139"],"gpt_icon":0},{"id":"2500298726","title":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500298726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500298726?lang=en_us&edition=fundamental","pubTime":"2025-01-01 06:52","pubTimestamp":1735685565,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Adicet Bio Inc ACET.O:ADICET BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw4NKnnLaFurther company coverage: ACET.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA1RCZXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","ACET","BK4585","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","BK4139"],"gpt_icon":0},{"id":"2500623313","title":"Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500623313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500623313?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:48","pubTimestamp":1735681680,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA1RCZXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4112","NDAQ","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","ACET"],"gpt_icon":0},{"id":"2500625479","title":"Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500625479","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500625479?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:48","pubTimestamp":1735681680,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, December 31, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on December 31, 2024.The above-described award was granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The award was authorized by the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employee entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grant-214800519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","BK4139","LU2095319765.USD","ACET","IE00B3QW5Z07.USD",".IXIC","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","NDAQ"],"gpt_icon":0},{"id":"2492121159","title":"Adicet Bio says 1st  patient dosed in Phase1 trial of ADI-270 to treat ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121159","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492121159?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:10","pubTimestamp":1734610215,"startTime":"0","endTime":"0","summary":"Adicet Bio (ACET) announced that the first patient has been dosed in the Phase 1 clinical trial evaluating ADI-270 in patients with metastatic/adva...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adicet-bio-says-1st-patient-dosed-in-phase1-trial-of-adi-270-to-treat-ccrcc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adicet-bio-says-1st-patient-dosed-in-phase1-trial-of-adi-270-to-treat-ccrcc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BD6J9T35.USD","LU0109392836.USD","LU1670710661.SGD","LU0957808578.USD","IE00B5949003.HKD","LU1992135399.USD","BK4512","LU1861214812.USD","LU2237443622.USD","LU1074936037.SGD","LU2237443978.SGD","IE0009356076.USD","LU1803068979.SGD","LU0314104364.USD","LU2272731782.SGD","LU0124384867.USD","LU1244550494.USD","BK4139","BK4141","LU1642822529.SGD","LU2360107325.USD","LU0444971666.USD","LU1244550577.SGD","LU1670711040.USD","LU0724618433.USD","LU0889565833.HKD","LU2458330243.SGD","LU1670711123.USD","LU2272731600.USD","LU1244550221.USD","LU2237443549.SGD","LU2458330169.SGD","LU1978683503.SGD","IE00BZ199S13.USD","ACET","BK4585","LU1861219969.SGD","LU1992135472.HKD","LU2237438978.USD","LU1815336760.USD","LU0719512351.SGD","BK4561","LU0082616367.USD","BK4588","LU2298322129.HKD","LU1670710588.SGD","BK4515","LU2237443382.USD","ADI"],"gpt_icon":0},{"id":"2492129119","title":"Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of Adi-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492129119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492129119?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA4XWJXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2492121011","title":"Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121011","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492121011?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609600,"startTime":"0","endTime":"0","summary":"Company expects to share preliminary Phase 1 clinical data in the first half of 2025. For more information about becoming a study site, please email clinicaltrials@adicetbio.com.ADI-270 is an armored allogeneic \"off-the-shelf\" gamma delta CAR T cell therapy candidate targeting CD70-positive cancers. CD70 is a compelling target due to its high expression in both solid and hematological malignancies. ADI-270 is engineered with a third-generation CAR designed to target CD70 using its natural receptor, CD27, as the binding moiety and is further armored with a dominant negative form of the transforming growth factor-β receptor II  to provide functional resilience to the immunosuppressive tumor microenvironment. ADI-270 is also designed to increase exposure and persistence by reducing susceptibility to host vs. graft eliminati","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/U2gCb0_Nvz2zIIPCmTN9TA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/49f0cf03f173e43dd83ce55b7c3c1a52","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/U2gCb0_Nvz2zIIPCmTN9TA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/49f0cf03f173e43dd83ce55b7c3c1a52"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-announces-first-patient-120000866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0082616367.USD","LU1815336760.USD","LU2237443382.USD","BK4515","LU1244550494.USD","LU0724618433.USD","IE00B7SZL793.SGD","LU2458330169.SGD","AEIS","LU1244550221.USD","LU1670710661.SGD","LU1642822529.SGD","LU2298322129.HKD","IE00B66KJ199.SGD","BK4585","LU0957808578.USD","BK4157","IE00BD6J9T35.USD","BK4561","LU1244550577.SGD","LU1670711040.USD","LU1992135472.HKD","IE00B5949003.HKD","BK4588","LU0889565833.HKD","LU1670711123.USD","LU1861214812.USD","ADI","ACET","LU0124384867.USD","LU1670710588.SGD","IE0009356076.USD","IE00BZ199S13.USD","LU2237438978.USD","LU2237443622.USD","RCC","IE00B19Z4B17.USD","LU2458330243.SGD","BK4139","LU2237443978.SGD","LU0719512351.SGD","LU2272731600.USD","LU0314104364.USD","LU2272731782.SGD","LU1861219969.SGD","LU0109392836.USD","LU1992135399.USD","LU2237443549.SGD","LU1074936037.SGD","LU2360107325.USD"],"gpt_icon":0},{"id":"2492690028","title":"BRIEF-Adicet Bio Appoints Julie Maltzman, M.D. As Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492690028","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492690028?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:41","pubTimestamp":1734525715,"startTime":"0","endTime":"0","summary":"Dec 18 (Reuters) - Adicet Bio Inc   :   * ADICET BIO APPOINTS JULIE MALTZMAN, M.D. AS CHIEF MEDICAL OFFICERSource text:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2492902986","title":"Adicet Bio Appoints Julie Maltzman, M.d. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492902986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492902986?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:00","pubTimestamp":1734523202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA9D58WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2492900234","title":"Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492900234","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492900234?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:00","pubTimestamp":1734523200,"startTime":"0","endTime":"0","summary":"Dr. Maltzman Brings Oncology and Autoimmune Experience in All Stages of Drug Development, from Early-Stage Research to Successful Regulatory Approvals and Commercialization. REDWOOD CITY, Calif. & BOSTON, December 18, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the appointment of Julie Maltzman, M.D. as Chief Medical Officer, effective January 13, 2025. Dr. Maltzman will lead the Adicet clinical development strategy to advance Adicet’s robust autoimmune and oncology pipeline.She joins Adicet from IconOVir Bio where she served as Chief Medical Officer leading, designing, and executing on a clinical development program focused on refractory solid tumors. Prior to that, she served as the VP, Global Head of GI Cancers and Cancer Immunotherapy at Roche/Genentech. There, Dr. Maltzman oversaw the suc","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/D_og.zft9AbsCJg0VzAZcw--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f6363d7da4f63e3f8271b2f786424898","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/D_og.zft9AbsCJg0VzAZcw--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f6363d7da4f63e3f8271b2f786424898"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-appoints-julie-maltzman-120000482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GSK.UK","BK4007","GSK","LU1829250122.USD","BK4585","BK4588","ACET","BK4532","KOL","BK4139"],"gpt_icon":0},{"id":"2487751647","title":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2487751647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487751647?lang=en_us&edition=fundamental","pubTime":"2024-11-30 07:14","pubTimestamp":1732922045,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Nov 29 (Reuters) - Adicet Bio Inc ACET.O:ADICET BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw5w7b7kaFurther company coverage: ACET.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUA66YKB1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","NDAQ","BK4139","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","ACET","LU2095319765.USD","BK4585","BK4112","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD"],"gpt_icon":0},{"id":"2487139295","title":"Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2487139295","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487139295?lang=en_us&edition=fundamental","pubTime":"2024-11-30 05:44","pubTimestamp":1732916640,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, November 29, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 29, 2024.The above-described award was granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The award was authorized by the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employee entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grant-214400479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","BK4585","IE00BGHQF748.EUR","BK4588","BK4112","BK4139",".IXIC","ACET","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2484981852","title":"Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2484981852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484981852?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:06","pubTimestamp":1731963971,"startTime":"0","endTime":"0","summary":"The company states: “Adicet Bio (ACET) announced the opening of enrollment for the Phase 1 clinical trial evaluating ADI-270 in patients with metas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adicet-bio-opens-enrollment-for-adi-270-phase-1-clinical-trial-in-ccrcc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adicet-bio-opens-enrollment-for-adi-270-phase-1-clinical-trial-in-ccrcc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550221.USD","LU0444971666.USD","BK4585","LU0124384867.USD","LU1670711123.USD","LU1670710661.SGD","LU2458330243.SGD","BK4141","BK4515","LU1861214812.USD","LU0109392836.USD","LU0314104364.USD","LU1803068979.SGD","LU0719512351.SGD","LU2458330169.SGD","LU1670710588.SGD","LU0724618433.USD","LU1670711040.USD","LU1244550494.USD","LU0889565833.HKD","LU2237443382.USD","LU1244550577.SGD","LU1642822529.SGD","LU1992135472.HKD","LU2272731782.SGD","BK4561","LU1861219969.SGD","LU0082616367.USD","BK4512","LU1992135399.USD","BK4588","LU1074936037.SGD","LU1815336760.USD","LU1978683503.SGD","LU2237443549.SGD","LU2360107325.USD","IE00BD6J9T35.USD","LU2272731600.USD","LU2298322129.HKD","IE00BZ199S13.USD","BK4139","LU2237443622.USD","LU2237438978.USD","ACET","IE00B5949003.HKD","IE0009356076.USD","LU2237443978.SGD","ADI","LU0957808578.USD"],"gpt_icon":0},{"id":"2484986713","title":"Adicet Opens Enrollment for Adi-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2484986713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484986713?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:00","pubTimestamp":1731963600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA6STTZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"ACET","fiscalQuarterEnding":"2024/12","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-11-06","symbol":"ACET","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-08-13","symbol":"ACET","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-05-14","symbol":"ACET","fiscalQuarterEnding":"2024/03","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2024-03-19","symbol":"ACET","fiscalQuarterEnding":"2023/12","expectedEps":-0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"post","actualEps":-0.69}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1727928000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACET","date":"2025-04-21","current":-0.371204,"percent":0.984028,"low":-20.788688,"twenty":-11.148097,"median":-4.755552,"eighty":-0.787682,"high":-0.315643,"avg":-5.827659,"sd":5.145633,"marketCap":43476167},"quantilePoints":[{"date":"2020-09-18","current":-12.223294,"twenty":-11.014673,"median":-9.201742,"eighty":-8.958418,"marketCap":419222319},{"date":"2020-09-25","current":-6.328696,"twenty":-9.039526,"median":-7.068377,"eighty":-6.14706,"marketCap":217055294},{"date":"2020-10-02","current":-6.791354,"twenty":-8.357534,"median":-6.791354,"eighty":-6.153914,"marketCap":232923054},{"date":"2020-10-09","current":-7.836617,"twenty":-7.781783,"median":-6.965564,"eighty":-6.372106,"marketCap":268772440},{"date":"2020-10-16","current":-7.72238,"twenty":-7.822909,"median":-7.21974,"eighty":-6.578874,"marketCap":264854474},{"date":"2020-10-23","current":-7.134063,"twenty":-7.77036,"median":-7.288282,"eighty":-6.791354,"marketCap":244676951},{"date":"2020-10-30","current":-6.123071,"twenty":-7.720095,"median":-7.15691,"eighty":-6.52861,"marketCap":210002956},{"date":"2020-11-06","current":-6.806308,"twenty":-7.709814,"median":-6.991267,"eighty":-6.430367,"marketCap":233442752},{"date":"2020-11-13","current":-7.600663,"twenty":-7.669831,"median":-6.996979,"eighty":-6.430367,"marketCap":260687541},{"date":"2020-11-20","current":-7.314924,"twenty":-7.615433,"median":-7.074903,"eighty":-6.437221,"marketCap":250887257},{"date":"2020-11-27","current":-7.103477,"twenty":-7.598377,"median":-7.117764,"eighty":-6.482916,"marketCap":243635047},{"date":"2020-12-04","current":-7.863543,"twenty":-7.620356,"median":-7.103477,"eighty":-6.690826,"marketCap":269703801},{"date":"2020-12-11","current":-7.177769,"twenty":-7.620356,"median":-7.145487,"eighty":-6.791354,"marketCap":246183121},{"date":"2020-12-18","current":-8.275008,"twenty":-7.647524,"median":-7.177769,"eighty":-6.794345,"marketCap":283816210},{"date":"2020-12-24","current":-8.200715,"twenty":-7.72238,"median":-7.206343,"eighty":-6.806308,"marketCap":281268136},{"date":"2020-12-31","current":-8.029272,"twenty":-7.842002,"median":-7.231164,"eighty":-6.81088,"marketCap":275387966},{"date":"2021-01-08","current":-7.840684,"twenty":-7.880687,"median":-7.274921,"eighty":-6.83031,"marketCap":268919779},{"date":"2021-01-15","current":-7.486367,"twenty":-7.864686,"median":-7.354927,"eighty":-6.841184,"marketCap":256767427},{"date":"2021-01-22","current":-8.309296,"twenty":-7.958409,"median":-7.448213,"eighty":-6.851749,"marketCap":284992244},{"date":"2021-01-29","current":-7.029185,"twenty":-7.965266,"median":-7.450146,"eighty":-6.865888,"marketCap":241086974},{"date":"2021-02-05","current":-7.240632,"twenty":-7.953837,"median":-7.354927,"eighty":-6.880317,"marketCap":248339183},{"date":"2021-02-12","current":-14.744768,"twenty":-7.988752,"median":-7.450146,"eighty":-6.910317,"marketCap":505716040},{"date":"2021-02-19","current":-14.71987,"twenty":-8.032701,"median":-7.472996,"eighty":-6.929451,"marketCap":504862118},{"date":"2021-02-26","current":-13.980224,"twenty":-8.198429,"median":-7.528178,"eighty":-6.940161,"marketCap":479493736},{"date":"2021-03-05","current":-12.510064,"twenty":-8.300152,"median":-7.586376,"eighty":-6.958322,"marketCap":429070163},{"date":"2021-03-12","current":-12.789081,"twenty":-8.654016,"median":-7.625279,"eighty":-6.977444,"marketCap":469077921},{"date":"2021-03-19","current":-12.606418,"twenty":-12.160165,"median":-7.660668,"eighty":-6.990125,"marketCap":462378194},{"date":"2021-03-26","current":-11.392595,"twenty":-12.364733,"median":-7.699533,"eighty":-6.998432,"marketCap":417857597},{"date":"2021-04-01","current":-11.366584,"twenty":-12.191729,"median":-7.716668,"eighty":-7.00404,"marketCap":416903584},{"date":"2021-04-09","current":-11.435946,"twenty":-12.010661,"median":-7.732957,"eighty":-7.020041,"marketCap":419447618},{"date":"2021-04-16","current":-10.61228,"twenty":-11.720327,"median":-7.806395,"eighty":-7.032614,"marketCap":389237214},{"date":"2021-04-23","current":-12.302962,"twenty":-11.720327,"median":-7.83865,"eighty":-7.050901,"marketCap":451248044},{"date":"2021-04-30","current":-13.811571,"twenty":-12.427812,"median":-7.869258,"eighty":-7.07376,"marketCap":506580786},{"date":"2021-05-07","current":-12.346313,"twenty":-12.499856,"median":-7.966409,"eighty":-7.094333,"marketCap":452838066},{"date":"2021-05-14","current":-11.636081,"twenty":-12.436483,"median":-7.996548,"eighty":-7.109192,"marketCap":426788194},{"date":"2021-05-21","current":-8.596808,"twenty":-12.339377,"median":-8.0207,"eighty":-7.132453,"marketCap":460023817},{"date":"2021-05-28","current":-7.978504,"twenty":-12.309898,"median":-8.029272,"eighty":-7.138632,"marketCap":426937733},{"date":"2021-06-04","current":-7.294802,"twenty":-12.302962,"median":-7.996548,"eighty":-7.15691,"marketCap":390352160},{"date":"2021-06-11","current":-6.98565,"twenty":-12.223294,"median":-7.975314,"eighty":-7.132051,"marketCap":373809118},{"date":"2021-06-18","current":-6.266277,"twenty":-12.065471,"median":-7.949265,"eighty":-7.069188,"marketCap":335314732},{"date":"2021-06-25","current":-5.766877,"twenty":-11.817433,"median":-7.852113,"eighty":-7.000611,"marketCap":308591357},{"date":"2021-07-02","current":-5.903617,"twenty":-11.791422,"median":-7.835818,"eighty":-6.985555,"marketCap":315908472},{"date":"2021-07-09","current":-5.499341,"twenty":-11.667149,"median":-7.806395,"eighty":-6.932583,"marketCap":294275263},{"date":"2021-07-16","current":-4.637283,"twenty":-11.621631,"median":-7.77184,"eighty":-6.854786,"marketCap":248145627},{"date":"2021-07-23","current":-4.833475,"twenty":-11.479297,"median":-7.720674,"eighty":-6.81088,"marketCap":258644096},{"date":"2021-07-30","current":-4.399473,"twenty":-11.43768,"median":-7.704389,"eighty":-6.63694,"marketCap":235420210},{"date":"2021-08-06","current":-4.155719,"twenty":-11.435946,"median":-7.66924,"eighty":-6.406377,"marketCap":222376658},{"date":"2021-08-13","current":-4.402445,"twenty":-11.401265,"median":-7.627258,"eighty":-6.225849,"marketCap":246140692},{"date":"2021-08-20","current":-3.941128,"twenty":-11.371786,"median":-7.589233,"eighty":-6.116457,"marketCap":220348459},{"date":"2021-08-27","current":-4.596084,"twenty":-11.366584,"median":-7.547276,"eighty":-6.002308,"marketCap":256967062},{"date":"2021-09-03","current":-4.533436,"twenty":-11.345776,"median":-7.482484,"eighty":-5.806364,"marketCap":253464413},{"date":"2021-09-10","current":-4.334102,"twenty":-11.309361,"median":-7.452079,"eighty":-5.73834,"marketCap":242319621},{"date":"2021-09-17","current":-4.0949,"twenty":-11.288553,"median":-7.415748,"eighty":-5.46367,"marketCap":228945870},{"date":"2021-09-24","current":-4.328406,"twenty":-11.283351,"median":-7.354927,"eighty":-5.029668,"marketCap":242001198},{"date":"2021-10-01","current":-4.630256,"twenty":-11.274681,"median":-7.307836,"eighty":-4.803749,"marketCap":258877598},{"date":"2021-10-08","current":-4.197415,"twenty":-11.250823,"median":-7.276966,"eighty":-4.755552,"marketCap":234677478},{"date":"2021-10-15","current":-4.578998,"twenty":-11.231609,"median":-7.234917,"eighty":-4.643318,"marketCap":256011794},{"date":"2021-10-22","current":-4.61317,"twenty":-11.191447,"median":-7.21974,"eighty":-4.634472,"marketCap":257922330},{"date":"2021-10-29","current":-4.897933,"twenty":-11.161969,"median":-7.180626,"eighty":-4.634472,"marketCap":273843461},{"date":"2021-11-05","current":-5.23965,"twenty":-11.142894,"median":-7.166339,"eighty":-4.643318,"marketCap":292948819},{"date":"2021-11-12","current":-5.650037,"twenty":-11.101277,"median":-7.134172,"eighty":-4.661011,"marketCap":311565637},{"date":"2021-11-19","current":-5.395061,"twenty":-11.075267,"median":-7.103477,"eighty":-4.700877,"marketCap":297505239},{"date":"2021-11-26","current":-5.447215,"twenty":-11.050991,"median":-7.080774,"eighty":-4.730547,"marketCap":300381230},{"date":"2021-12-03","current":-5.679011,"twenty":-11.002438,"median":-7.037757,"eighty":-4.748799,"marketCap":313163410},{"date":"2021-12-10","current":-9.859615,"twenty":-10.830768,"median":-7.080774,"eighty":-4.755552,"marketCap":543698631},{"date":"2021-12-17","current":-11.250893,"twenty":-10.84203,"median":-7.117764,"eighty":-4.75783,"marketCap":620419244},{"date":"2021-12-23","current":-11.300581,"twenty":-11.061395,"median":-7.134172,"eighty":-4.762613,"marketCap":623159266},{"date":"2021-12-31","current":-12.415023,"twenty":-11.108913,"median":-7.166339,"eighty":-4.768078,"marketCap":684614043},{"date":"2022-01-07","current":-11.016647,"twenty":-11.165437,"median":-7.180626,"eighty":-4.774685,"marketCap":607501998},{"date":"2022-01-14","current":-10.335205,"twenty":-11.153299,"median":-7.21974,"eighty":-4.806397,"marketCap":569924555},{"date":"2022-01-21","current":-8.468338,"twenty":-11.13249,"median":-7.234917,"eighty":-4.82753,"marketCap":466978018},{"date":"2022-01-28","current":-8.297977,"twenty":-11.116024,"median":-7.258799,"eighty":-4.833475,"marketCap":457583657},{"date":"2022-02-04","current":-8.951026,"twenty":-11.080469,"median":-7.300747,"eighty":-4.869457,"marketCap":493595373},{"date":"2022-02-11","current":-11.094729,"twenty":-11.080469,"median":-7.350163,"eighty":-4.875092,"marketCap":611807747},{"date":"2022-02-18","current":-9.66796,"twenty":-11.071799,"median":-7.413707,"eighty":-4.897933,"marketCap":533129975},{"date":"2022-02-25","current":-9.75314,"twenty":-11.030182,"median":-7.448213,"eighty":-4.938939,"marketCap":537827155},{"date":"2022-03-04","current":-8.915534,"twenty":-11.017273,"median":-7.472996,"eighty":-4.958303,"marketCap":491638215},{"date":"2022-03-11","current":-9.305944,"twenty":-11.010969,"median":-7.528178,"eighty":-4.97425,"marketCap":513166958},{"date":"2022-03-18","current":-10.355352,"twenty":-11.009549,"median":-7.586376,"eighty":-4.990731,"marketCap":642021454},{"date":"2022-03-25","current":-11.06286,"twenty":-11.009549,"median":-7.625279,"eighty":-5.041559,"marketCap":685886274},{"date":"2022-04-01","current":-13.384775,"twenty":-11.028394,"median":-7.660668,"eighty":-5.170516,"marketCap":829842638},{"date":"2022-04-08","current":-11.731777,"twenty":-11.098988,"median":-7.699533,"eighty":-5.231677,"marketCap":727358468},{"date":"2022-04-14","current":-10.876335,"twenty":-11.12261,"median":-7.716668,"eighty":-5.249902,"marketCap":674321913},{"date":"2022-04-22","current":-8.988146,"twenty":-11.103247,"median":-7.732957,"eighty":-5.26357,"marketCap":557256054},{"date":"2022-04-29","current":-9.510787,"twenty":-11.086173,"median":-7.802346,"eighty":-5.278378,"marketCap":589659313},{"date":"2022-05-06","current":-9.678549,"twenty":-11.077622,"median":-7.829679,"eighty":-5.295464,"marketCap":600060360},{"date":"2022-05-13","current":-13.123275,"twenty":-11.086173,"median":-7.836617,"eighty":-5.305715,"marketCap":473251543},{"date":"2022-05-20","current":-11.769903,"twenty":-11.161969,"median":-7.861263,"eighty":-5.31851,"marketCap":424446227},{"date":"2022-05-27","current":-13.034529,"twenty":-11.242695,"median":-7.869258,"eighty":-5.340635,"marketCap":470051194},{"date":"2022-06-03","current":-12.757199,"twenty":-11.285085,"median":-7.960694,"eighty":-5.368451,"marketCap":460050105},{"date":"2022-06-10","current":-13.234207,"twenty":-11.327253,"median":-7.981029,"eighty":-5.399697,"marketCap":477251979},{"date":"2022-06-17","current":-13.00125,"twenty":-11.375618,"median":-8.012128,"eighty":-5.411287,"marketCap":468851064},{"date":"2022-06-24","current":-15.120054,"twenty":-11.422222,"median":-8.034987,"eighty":-5.419003,"marketCap":545259385},{"date":"2022-07-01","current":-16.284842,"twenty":-11.553978,"median":-8.091112,"eighty":-5.423608,"marketCap":587263960},{"date":"2022-07-08","current":-20.633383,"twenty":-11.719384,"median":-8.168751,"eighty":-5.42983,"marketCap":744081040},{"date":"2022-07-15","current":-20.178561,"twenty":-11.769903,"median":-8.184404,"eighty":-5.44142,"marketCap":727679253},{"date":"2022-07-22","current":-18.913934,"twenty":-11.969581,"median":-8.226432,"eighty":-5.44142,"marketCap":682074286},{"date":"2022-07-29","current":-18.736442,"twenty":-12.060106,"median":-8.275008,"eighty":-5.447215,"marketCap":675673589},{"date":"2022-08-05","current":-20.788688,"twenty":-12.223294,"median":-8.303636,"eighty":-5.46367,"marketCap":749681650},{"date":"2022-08-12","current":-13.750684,"twenty":-12.362103,"median":-8.343585,"eighty":-5.46367,"marketCap":656540161},{"date":"2022-08-19","current":-12.768492,"twenty":-12.509551,"median":-8.420735,"eighty":-5.499341,"marketCap":609644435},{"date":"2022-08-26","current":-12.813137,"twenty":-12.536338,"median":-8.482534,"eighty":-5.510959,"marketCap":611776059},{"date":"2022-09-02","current":-12.777421,"twenty":-12.592247,"median":-8.603556,"eighty":-5.516754,"marketCap":610070760},{"date":"2022-09-09","current":-14.634657,"twenty":-12.609234,"median":-8.645174,"eighty":-5.544569,"marketCap":698746314},{"date":"2022-09-16","current":-14.072129,"twenty":-12.704679,"median":-8.738075,"eighty":-5.600145,"marketCap":671887853},{"date":"2022-09-23","current":-12.411332,"twenty":-12.737344,"median":-8.830852,"eighty":-5.64249,"marketCap":592591444},{"date":"2022-09-30","current":-12.69706,"twenty":-12.737344,"median":-8.887141,"eighty":-5.673216,"marketCap":606233837},{"date":"2022-10-07","current":-13.304233,"twenty":-12.761349,"median":-8.922632,"eighty":-5.692229,"marketCap":635223922},{"date":"2022-10-14","current":-14.831095,"twenty":-12.793892,"median":-8.951026,"eighty":-5.705496,"marketCap":708125459},{"date":"2022-10-21","current":-15.473984,"twenty":-12.959137,"median":-8.99443,"eighty":-5.755099,"marketCap":738820843},{"date":"2022-10-28","current":-15.348978,"twenty":-13.011811,"median":-9.007813,"eighty":-5.766877,"marketCap":732852296},{"date":"2022-11-04","current":-15.956151,"twenty":-13.109866,"median":-9.211253,"eighty":-5.781146,"marketCap":761842381},{"date":"2022-11-11","current":-16.355298,"twenty":-13.154285,"median":-9.27755,"eighty":-5.806364,"marketCap":911448044},{"date":"2022-11-18","current":-13.51023,"twenty":-13.225939,"median":-9.316592,"eighty":-5.88173,"marketCap":752898078},{"date":"2022-11-25","current":-13.187276,"twenty":-13.261571,"median":-9.354812,"eighty":-5.901857,"marketCap":734900515},{"date":"2022-12-02","current":-14.809734,"twenty":-13.320734,"median":-9.452716,"eighty":-5.911914,"marketCap":825316846},{"date":"2022-12-09","current":-13.279548,"twenty":-13.423882,"median":-9.515167,"eighty":-5.934118,"marketCap":740042676},{"date":"2022-12-16","current":-7.228011,"twenty":-13.398989,"median":-9.452716,"eighty":-5.976733,"marketCap":402802614},{"date":"2022-12-23","current":-6.097673,"twenty":-13.354338,"median":-9.354812,"eighty":-6.009039,"marketCap":339811142},{"date":"2022-12-30","current":-6.8743,"twenty":-13.325172,"median":-9.316592,"eighty":-6.00527,"marketCap":383090997},{"date":"2023-01-06","current":-6.443695,"twenty":-13.310335,"median":-9.281099,"eighty":-6.018456,"marketCap":359094245},{"date":"2023-01-13","current":-6.682066,"twenty":-13.30391,"median":-9.220763,"eighty":-5.960806,"marketCap":372378161},{"date":"2023-01-20","current":-6.797406,"twenty":-13.302617,"median":-9.171075,"eighty":-5.997732,"marketCap":378805863},{"date":"2023-01-27","current":-6.889679,"twenty":-13.279548,"median":-9.004264,"eighty":-6.016577,"marketCap":383948024},{"date":"2023-02-03","current":-6.735891,"twenty":-13.234207,"median":-8.958124,"eighty":-6.02597,"marketCap":375377755},{"date":"2023-02-10","current":-6.236082,"twenty":-13.225723,"median":-8.933129,"eighty":-6.037393,"marketCap":347524383},{"date":"2023-02-17","current":-6.489831,"twenty":-13.223872,"median":-8.915534,"eighty":-6.037393,"marketCap":361665326},{"date":"2023-02-24","current":-5.89006,"twenty":-13.194595,"median":-8.860478,"eighty":-6.03412,"marketCap":328241279},{"date":"2023-03-03","current":-5.982333,"twenty":-13.171574,"median":-8.80263,"eighty":-6.012808,"marketCap":333383440},{"date":"2023-03-10","current":-5.490213,"twenty":-13.16286,"median":-8.723879,"eighty":-5.944964,"marketCap":305958581},{"date":"2023-03-17","current":-4.573083,"twenty":-13.154285,"median":-8.610305,"eighty":-5.932447,"marketCap":319155464},{"date":"2023-03-24","current":-3.62523,"twenty":-13.129108,"median":-8.483849,"eighty":-5.897386,"marketCap":253004802},{"date":"2023-03-31","current":-3.545216,"twenty":-13.118034,"median":-8.454537,"eighty":-5.866992,"marketCap":247420656},{"date":"2023-04-06","current":-3.37288,"twenty":-13.113999,"median":-8.398808,"eighty":-5.809257,"marketCap":235393263},{"date":"2023-04-14","current":-3.557526,"twenty":-13.110445,"median":-8.342168,"eighty":-5.748484,"marketCap":248279755},{"date":"2023-04-21","current":-3.723921,"twenty":-13.086876,"median":-8.297405,"eighty":-5.667421,"marketCap":259892457},{"date":"2023-04-28","current":-3.55773,"twenty":-13.049491,"median":-8.275008,"eighty":-5.514436,"marketCap":248293951},{"date":"2023-05-05","current":-3.927044,"twenty":-13.024915,"median":-8.226432,"eighty":-5.46367,"marketCap":274068409},{"date":"2023-05-12","current":-2.71725,"twenty":-13.015752,"median":-8.184404,"eighty":-5.436784,"marketCap":286096490},{"date":"2023-05-19","current":-2.63566,"twenty":-13.012337,"median":-8.176277,"eighty":-5.402015,"marketCap":277506005},{"date":"2023-05-26","current":-2.256223,"twenty":-13.01026,"median":-8.097409,"eighty":-5.305715,"marketCap":237555450},{"date":"2023-06-02","current":-2.119544,"twenty":-13.006246,"median":-8.052131,"eighty":-5.261292,"marketCap":223164659},{"date":"2023-06-09","current":-2.313342,"twenty":-12.997558,"median":-8.029272,"eighty":-5.082716,"marketCap":243569512},{"date":"2023-06-16","current":-1.848226,"twenty":-12.976876,"median":-8.004338,"eighty":-4.951469,"marketCap":194597864},{"date":"2023-06-23","current":-1.782946,"twenty":-12.959137,"median":-7.983554,"eighty":-4.873965,"marketCap":187724650},{"date":"2023-06-30","current":-0.942473,"twenty":-12.911961,"median":-7.972124,"eighty":-4.816964,"marketCap":99232023},{"date":"2023-07-07","current":-1.28111,"twenty":-12.868469,"median":-7.949265,"eighty":-4.763979,"marketCap":134886820},{"date":"2023-07-14","current":-1.31783,"twenty":-12.843199,"median":-7.863618,"eighty":-4.74542,"marketCap":138753002},{"date":"2023-07-21","current":-1.207671,"twenty":-12.830007,"median":-7.840684,"eighty":-4.656454,"marketCap":127154454},{"date":"2023-07-28","current":-1.019992,"twenty":-12.803515,"median":-7.829679,"eighty":-4.602918,"marketCap":107393965},{"date":"2023-08-04","current":-0.966953,"twenty":-12.784417,"median":-7.802346,"eighty":-4.569798,"marketCap":101809478},{"date":"2023-08-11","current":-0.878871,"twenty":-12.773849,"median":-7.732957,"eighty":-4.533436,"marketCap":101205471},{"date":"2023-08-18","current":-0.736755,"twenty":-12.768492,"median":-7.716668,"eighty":-4.477622,"marketCap":84840331},{"date":"2023-08-25","current":-0.654478,"twenty":-12.76492,"median":-7.684387,"eighty":-4.455547,"marketCap":75365776},{"date":"2023-09-01","current":-0.747975,"twenty":-12.758617,"median":-7.652096,"eighty":-4.400662,"marketCap":86132316},{"date":"2023-09-08","current":-0.665698,"twenty":-12.756521,"median":-7.629237,"eighty":-4.34242,"marketCap":76657761},{"date":"2023-09-15","current":-0.669438,"twenty":-12.75227,"median":-7.594948,"eighty":-4.312673,"marketCap":77088422},{"date":"2023-09-22","current":-0.572201,"twenty":-12.743915,"median":-7.566374,"eighty":-4.236574,"marketCap":65891221},{"date":"2023-09-29","current":-0.531062,"twenty":-12.727534,"median":-7.484426,"eighty":-4.198554,"marketCap":61153944},{"date":"2023-10-06","current":-0.493664,"twenty":-12.69706,"median":-7.452079,"eighty":-4.156908,"marketCap":56847328},{"date":"2023-10-13","current":-0.504883,"twenty":-12.691703,"median":-7.415748,"eighty":-4.13135,"marketCap":58139313},{"date":"2023-10-20","current":-0.546022,"twenty":-12.664916,"median":-7.354927,"eighty":-4.067563,"marketCap":62876590},{"date":"2023-10-27","current":-0.478704,"twenty":-12.654201,"median":-7.3454,"eighty":-4.043715,"marketCap":55124682},{"date":"2023-11-03","current":-0.553502,"twenty":-12.626447,"median":-7.297775,"eighty":-4.002637,"marketCap":63737913},{"date":"2023-11-10","current":-0.376337,"twenty":-12.610697,"median":-7.240632,"eighty":-3.935494,"marketCap":53832697},{"date":"2023-11-17","current":-0.353056,"twenty":-12.606959,"median":-7.23304,"eighty":-3.832918,"marketCap":50502490},{"date":"2023-11-24","current":-0.359091,"twenty":-12.604608,"median":-7.223876,"eighty":-3.775539,"marketCap":51365781},{"date":"2023-12-01","current":-0.356073,"twenty":-12.598035,"median":-7.183484,"eighty":-3.742387,"marketCap":50934135},{"date":"2023-12-08","current":-0.413407,"twenty":-12.591669,"median":-7.172054,"eighty":-3.680708,"marketCap":59135395},{"date":"2023-12-15","current":-0.497899,"twenty":-12.589369,"median":-7.134281,"eighty":-3.606889,"marketCap":71221461},{"date":"2023-12-22","current":-0.4466,"twenty":-12.584725,"median":-7.117764,"eighty":-3.56011,"marketCap":63883492},{"date":"2023-12-29","current":-0.525057,"twenty":-12.580983,"median":-7.097292,"eighty":-3.545216,"marketCap":75106268},{"date":"2024-01-05","current":-0.651795,"twenty":-12.554196,"median":-7.08698,"eighty":-3.493515,"marketCap":93235367},{"date":"2024-01-12","current":-0.917341,"twenty":-12.52908,"median":-7.069188,"eighty":-3.412271,"marketCap":131220146},{"date":"2024-01-19","current":-0.737796,"twenty":-12.524241,"median":-7.035777,"eighty":-3.263323,"marketCap":105537256},{"date":"2024-01-26","current":-1.324851,"twenty":-12.51857,"median":-7.023513,"eighty":-2.747451,"marketCap":189511962},{"date":"2024-02-02","current":-1.772434,"twenty":-12.509859,"median":-7.000611,"eighty":-2.585064,"marketCap":253536017},{"date":"2024-02-09","current":-1.938779,"twenty":-12.491736,"median":-6.991314,"eighty":-2.31987,"marketCap":277330659},{"date":"2024-02-16","current":-1.720809,"twenty":-12.462618,"median":-6.972037,"eighty":-2.243983,"marketCap":246151473},{"date":"2024-02-23","current":-1.399592,"twenty":-12.450225,"median":-6.949178,"eighty":-2.172992,"marketCap":200203198},{"date":"2024-03-01","current":-1.347967,"twenty":-12.414285,"median":-6.907999,"eighty":-1.977153,"marketCap":192818653},{"date":"2024-03-08","current":-1.370912,"twenty":-12.401486,"median":-6.8743,"eighty":-1.880799,"marketCap":196100673},{"date":"2024-03-15","current":-1.175886,"twenty":-12.358945,"median":-6.850352,"eighty":-1.832088,"marketCap":168203506},{"date":"2024-03-22","current":-1.174797,"twenty":-12.339673,"median":-6.835853,"eighty":-1.784285,"marketCap":167594127},{"date":"2024-03-28","current":-1.341802,"twenty":-12.313113,"median":-6.812023,"eighty":-1.720809,"marketCap":191418782},{"date":"2024-04-05","current":-1.313008,"twenty":-12.311632,"median":-6.801251,"eighty":-1.686393,"marketCap":187311083},{"date":"2024-04-12","current":-1.289973,"twenty":-12.302962,"median":-6.791354,"eighty":-1.588881,"marketCap":184024924},{"date":"2024-04-19","current":-1.16638,"twenty":-12.277396,"median":-6.697444,"eighty":-1.399592,"marketCap":166393446},{"date":"2024-04-26","current":-1.042542,"twenty":-12.223294,"median":-6.665694,"eighty":-1.382114,"marketCap":148726981},{"date":"2024-05-03","current":-0.812146,"twenty":-12.21417,"median":-6.589793,"eighty":-1.370912,"marketCap":115859140},{"date":"2024-05-10","current":-0.938864,"twenty":-12.197035,"median":-6.535968,"eighty":-1.357033,"marketCap":133936452},{"date":"2024-05-17","current":-0.922882,"twenty":-12.194874,"median":-6.505876,"eighty":-1.341802,"marketCap":129012399},{"date":"2024-05-24","current":-0.899369,"twenty":-12.179177,"median":-6.443695,"eighty":-1.324851,"marketCap":125725459},{"date":"2024-05-31","current":-0.869978,"twenty":-12.088212,"median":-6.437221,"eighty":-1.31375,"marketCap":121616784},{"date":"2024-06-07","current":-0.822952,"twenty":-12.061179,"median":-6.407834,"eighty":-1.306296,"marketCap":115042904},{"date":"2024-06-14","current":-0.852343,"twenty":-12.055847,"median":-6.386025,"eighty":-1.290353,"marketCap":119151579},{"date":"2024-06-21","current":-0.799439,"twenty":-12.037385,"median":-6.32468,"eighty":-1.28809,"marketCap":111755964},{"date":"2024-06-28","current":-0.787682,"twenty":-12.021764,"median":-6.317751,"eighty":-1.28111,"marketCap":110112494},{"date":"2024-07-05","current":-0.640727,"twenty":-12.000582,"median":-6.289626,"eighty":-1.264729,"marketCap":89569118},{"date":"2024-07-12","current":-0.740657,"twenty":-11.985072,"median":-6.236551,"eighty":-1.250908,"marketCap":103538613},{"date":"2024-07-15","current":-0.711265,"twenty":-11.982873,"median":-6.236317,"eighty":-1.24294,"marketCap":99429938},{"date":"2024-08-02","current":-0.887612,"twenty":-11.980674,"median":-6.236082,"eighty":-1.238143,"marketCap":124081989},{"date":"2024-08-09","current":-0.781804,"twenty":-11.969581,"median":-6.205324,"eighty":-1.199511,"marketCap":109290758},{"date":"2024-08-16","current":-0.858275,"twenty":-11.817433,"median":-6.189946,"eighty":-1.16638,"marketCap":117833372},{"date":"2024-08-23","current":-0.924296,"twenty":-11.792089,"median":-6.174413,"eighty":-1.118526,"marketCap":126897478},{"date":"2024-08-30","current":-0.888284,"twenty":-11.791422,"median":-6.123071,"eighty":-1.079982,"marketCap":121953420},{"date":"2024-09-06","current":-0.864276,"twenty":-11.774207,"median":-6.117646,"eighty":-1.042246,"marketCap":118657382},{"date":"2024-09-13","current":-0.918294,"twenty":-11.746525,"median":-6.097673,"eighty":-1.023256,"marketCap":126073468},{"date":"2024-09-20","current":-0.912292,"twenty":-11.737434,"median":-6.059226,"eighty":-1.003173,"marketCap":125249459},{"date":"2024-09-27","current":-0.840269,"twenty":-11.732746,"median":-6.031064,"eighty":-0.967521,"marketCap":115361344},{"date":"2024-10-04","current":-0.852273,"twenty":-11.721863,"median":-5.997732,"eighty":-0.951895,"marketCap":117009363},{"date":"2024-10-11","current":-0.840269,"twenty":-11.652742,"median":-5.948405,"eighty":-0.941944,"marketCap":115361344},{"date":"2024-10-18","current":-0.888284,"twenty":-11.621631,"median":-5.943886,"eighty":-0.924013,"marketCap":121953420},{"date":"2024-10-25","current":-0.852273,"twenty":-11.588658,"median":-5.911442,"eighty":-0.918294,"marketCap":117009363},{"date":"2024-10-31","current":-0.816261,"twenty":-11.499297,"median":-5.901417,"eighty":-0.916531,"marketCap":112065305},{"date":"2024-11-08","current":-0.92967,"twenty":-11.439414,"median":-5.89006,"eighty":-0.912292,"marketCap":109593276},{"date":"2024-11-15","current":-0.73395,"twenty":-11.435946,"median":-5.866992,"eighty":-0.903278,"marketCap":86521008},{"date":"2024-11-22","current":-0.638886,"twenty":-11.429986,"median":-5.811777,"eighty":-0.89627,"marketCap":75314477},{"date":"2024-11-29","current":-0.78987,"twenty":-11.418431,"median":-5.784713,"eighty":-0.894286,"marketCap":93113084},{"date":"2024-12-06","current":-0.690193,"twenty":-11.401272,"median":-5.743886,"eighty":-0.888284,"marketCap":81362707},{"date":"2024-12-13","current":-0.681106,"twenty":-11.388213,"median":-5.695534,"eighty":-0.884414,"marketCap":80291495},{"date":"2024-12-20","current":-0.60135,"twenty":-11.375618,"median":-5.631169,"eighty":-0.87628,"marketCap":70889545},{"date":"2024-12-27","current":-0.67104,"twenty":-11.366584,"median":-5.534139,"eighty":-0.875575,"marketCap":79104921},{"date":"2025-01-03","current":-0.680687,"twenty":-11.366584,"median":-5.50515,"eighty":-0.869978,"marketCap":80242054},{"date":"2025-01-10","current":-0.67104,"twenty":-11.36489,"median":-5.476941,"eighty":-0.863653,"marketCap":79104921},{"date":"2025-01-17","current":-0.642801,"twenty":-11.345353,"median":-5.447215,"eighty":-0.858275,"marketCap":75775922},{"date":"2025-01-24","current":-0.659437,"twenty":-11.320593,"median":-5.44142,"eighty":-0.858275,"marketCap":77737065},{"date":"2025-01-31","current":-0.62211,"twenty":-11.303257,"median":-5.420147,"eighty":-0.852343,"marketCap":73336854},{"date":"2025-02-07","current":-0.71997,"twenty":-11.293364,"median":-5.395061,"eighty":-0.852273,"marketCap":84872988},{"date":"2025-02-14","current":-0.628751,"twenty":-11.288553,"median":-5.316757,"eighty":-0.84661,"marketCap":74119663},{"date":"2025-02-21","current":-0.699,"twenty":-11.285085,"median":-5.293755,"eighty":-0.846349,"marketCap":82400960},{"date":"2025-02-28","current":-0.600861,"twenty":-11.276415,"median":-5.256736,"eighty":-0.840269,"marketCap":70831865},{"date":"2025-03-07","current":-0.591354,"twenty":-11.263085,"median":-5.126616,"eighty":-0.836632,"marketCap":69711212},{"date":"2025-03-14","current":-0.54777,"twenty":-11.245427,"median":-4.977667,"eighty":-0.828729,"marketCap":64155873},{"date":"2025-03-21","current":-0.53958,"twenty":-11.234373,"median":-4.923562,"eighty":-0.822952,"marketCap":63196718},{"date":"2025-03-28","current":-0.600083,"twenty":-11.229199,"median":-4.869457,"eighty":-0.813792,"marketCap":70282887},{"date":"2025-04-04","current":-0.473712,"twenty":-11.203586,"median":-4.814322,"eighty":-0.799439,"marketCap":55482138},{"date":"2025-04-11","current":-0.315643,"twenty":-11.163703,"median":-4.768078,"eighty":-0.793561,"marketCap":36968798},{"date":"2025-04-17","current":-0.403326,"twenty":-11.153299,"median":-4.755552,"eighty":-0.78812,"marketCap":47238368},{"date":"2025-04-21","current":-0.371204,"twenty":-11.148097,"median":-4.755552,"eighty":-0.787682,"marketCap":43476167}],"updateTime":1745338269897}}}